AUROPHARMA Update on Thursday 28th Aug 2014
Open 825.70 Change Price %
High 828.75 1 Day -7.15 -0.87
Low 812.35 1 Week 8.15 1.01
Close 817.55 1 Month 139.65 20.60
Volume 1614029 1 Year 638.85 357.50
52 Week High 834.95
52 Week Low 170.70
AUROPHARMA Important Levels
Resistance 2 832.75
Resistance 1 826.49
Pivot 819.55
Support 1 808.61
Support 2 802.35
AUROPHARMA CURRENT MONTH FUTURE
Close 817.20
Contracts Traded 8565
Open Intrest 1306000
Change In O.I -2031000
Lot Size 500
AUROPHARMA CURRENT MONTH OPTION
Most Active Call 820
Most Active put 820
Highest O.I Buildup Call 820
Highest O.I Buildup Put 700
Expiry Date 28-Aug-2014
AUROPHARMA ALL MONTHS OPTIONS
For All AUROPHARMA Options Click Here
NSE INDIA Most Active Stocks
NIFTY 7954.35 0.23%
JPASSOCIAT 46.50 -4.12%
UNITECH 21.70 -1.59%
GMRINFRA 25.35 1.60%
JPPOWER 14.15 -5.03%
ALOKTEXT 12.70 -3.05%
DABUR 232.60 0.15%
NHPC 21.65 3.34%
DLF 177.30 -3.06%
ASHOKLEY 36.45 -0.68%
More..
NSE INDIA Top Gainers Stocks
ANTGRAPHIC 0.20 33.33%
ESSDEE 502.75 19.42%
ASAHISONG 175.20 19.26%
GKB 56.25 17.19%
VISESHINFO 0.35 16.67%
GINNIFILA 15.40 15.79%
REISIXTEN 0.40 14.29%
AARVEEDEN 50.60 12.57%
KBIL 1505.80 12.37%
DREDGECORP 449.25 10.95%
More..
NSE INDIA Top Losers Stocks
MANINFRA 30.65 -80.93%
FEDDERLOYD 75.00 -19.83%
FCSSOFT 0.30 -14.29%
SRGINFOTEC 0.30 -14.29%
SAKTHIFIN 20.10 -9.87%
CTE 6.25 -9.42%
CTE 6.25 -9.42%
CTE 6.25 -9.42%
RAMKY 58.75 -8.63%
MAANALU 22.05 -8.12%
More..

Free Three Days Bazaartrend Advanced Plus Demo

AUROPHARMA Technical Analysis
As on Thursday 28th Aug 2014 AUROPHARMA closed @ 817.55 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 497.06 and Strong Buy for SHORT-TERM with Stoploss of 735.73 we also expect STOCK to react on Following IMPORTANT LEVELS.
AUROPHARMA Targets for August
1st Target up-side 790.05
2nd Target up-side 844.62
3rd Target up-side 899.19
1st Target down-side 634.35
2nd Target down-side 579.78
3rd Target down-side 525.21

AUROPHARMA

synopsis Technicals View
50 Day EMA Close is Above EMA 50 (Short Term)
Bullish
100 Day EMA Close is Above EMA 100 (Mid Term) Bullish
200 Day EMA Close is Above EMA 200 (Long Term) Bullish
MACD (12 26 9) MACD Line is Grater Then SIGNAL Line Bullish
RSI (14) RSI is 68.32 Sideways
MFI (14) MFI is 54.52 Sideways
CCI (20) CCI is -13.16 Sideways
WILLIAM %R (14) William %R is -42.53 Sideways
ADX (14) ADX is Above 20 & +DI is Above -DI Up Trend
PSAR Stoploss For Long Buy 658.30
10 Day Avg Volume Traded 16.95 % More then 10 Day Average Volume
AUROPHARMA Other Details
Segment EQ
Market Capital 25150871552.00
Sector Pharmaceuticals
Industry
Offical website
AUROPHARMA Address
AUROPHARMA
N/A
 
AUROPHARMA Latest News
Aurobindo Pharma tanks 5% despite strong fourth quarter nos   Moneycontrol.com   - 02nd Jun 14
TABLE-India's Aurobindo Pharma Jan-March net profit rises   Reuters   - 31st May 14
Aurobindo Pharma Q4 net spurts to Rs 501 cr   Hindu Business Line   - 30th May 14
Morgan Stanley sells Aurobindo Pharma shares worth Rs 116cr   Moneycontrol.com   - 30th May 14
Buy Aurobindo Pharma Ltd with a target of Rs 670: Mitesh Thacker   Economic Times   - 28th May 14
Reddy Becomes Billionaire as India's Aurobindo Shares Triple   Bloomberg   - 27th May 14
Aurobindo Pharma to announce FY14 results on May 30, 2014   Equity Bulls   - 27th May 14
Aurobindo Pharma rallies nearly 3%, hits fresh 52-week high on MSCI inclusion   Economic Times   - 15th May 14
Aurobindo Pharma hits new high   Business Standard   - 13th May 14
Aurobindo Pharma Limited   Moneycontrol.com   - 12th May 14

Interactive Technical Analysis Chart Aurobindo Pharma Limited ( AUROPHARMA NSE INDIA )

Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Aurobindo Pharma Limited
AUROPHARMA Business Profile
Aurobindo Pharm is in the Pharmaceuticals sector. Founded in 1986 by Mr. P.V. Ramaprasad Reddy, Mr. K. Nityananda Reddy and a small group of highly committed professionals, Aurobindo Pharma was born off a vision. The company commenced operations in 1988-89 with a single unit manufacturing Semi-Synthetic Penicillin (SSP) at Pondicherry. Aurobindo Pharma became a public company in 1992 and listed its shares in the Indian stock exchanges in 1995. In addition to being the market leader in Semi-Synthetic Penicillins, it has a presence in key therapeutic segments such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and cephalosporins, among others. Aurobindo makes use of in-house R&D for rapid filing of patents, Drug Master Files (DMFs), Abbreviated New Drug Applications (ANDAs) and formulation dossiers across the world. Aurobindo Pharma is among the largest filers of DMFs and ANDAs from India. The current market capitalisation stands at Rs 8,284.96 crore.The company has reported a consolidated sales of Rs 1913.86 crore and a Net Profit of Rs 233.86 crore for the quarter ended Sep 2013. The company management includes K Ragunathan - Non Executive Chairman, K Nithyananda Reddy - Vice Chairman & Whole Time Dir, N Govindarajan - Managing Director, M Sivakumaran - Whole Time Director, M Madan Mohan Reddy - Whole Time Director, P V Ramprasad Reddy - Non Executive Director, P Sarath Chandra Reddy - Non Executive Director, M Sitarama Murthy - Non Executive Director, D Rajagopala Reddy - Non Executive Director, C Channa Reddy - Non Executive Director. It is listed on the BSE with a BSE Code of 524804 and the NSE with an NSE Code of AUROPHARMA. Its Registered office is at Plot No. 2, Maitrivihar,,Ameerpet Hyderabad,Andhra Pradesh - 500038.